Additional file 2: of A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freundâs adjuvant in melanoma patients

Melssen, Marit; Petroni, Gina; Chianese-Bullock, Kimberly; Wages, Nolan; Grosh, William; Varhegyi, Nikole; Smolkin, Mark; Smith, Kelly; Galeassi, Nadejda; Deacon, Donna; Gaughan, Elizabeth; Slingluff, Craig

doi:10.6084/m9.figshare.8342189.v1

Additional file 2: of A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freundâs adjuvant in melanoma patients

journal contribution

posted on 2019-06-27, 05:00 authored by Marit Melssen, Gina Petroni, Kimberly Chianese-Bullock, Nolan Wages, William Grosh, Nikole Varhegyi, Mark Smolkin, Kelly Smith, Nadejda Galeassi, Donna Deacon, Elizabeth Gaughan, Craig Slingluff

Supplemental Text. (DOCX 38 kb)

Funding

National Institutes of Health

History

Usage metrics

Keywords

Melanoma Peptide vaccine Incomplete freundâs adjuvant Toll-like receptor Lipopolysaccharide polyICLC Clinical trial CD8 T cells Immune response ELIspot

Licence

CC BY + CC0

Additional file 2: of A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freundâs adjuvant in melanoma patients

Funding

National Institutes of Health

History

Usage metrics

Categories

Keywords

Licence

Exports

Additional file 2: of A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freundâs adjuvant in melanoma patients

Funding

National Institutes of Health

History

Usage metrics

Categories

Keywords

Licence

Exports

Additional file 2: of A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freundâs adjuvant in melanoma patients